The mission of the Action Collaborative is to convene and catalyze public, private, and nonprofit stakeholders to develop, curate, and disseminate multisector solutions designed to reduce opioid misuse and improve outcomes for individuals, families, and communities affected by the opioid crisis.
The American Society of Health-Systems Pharmacists has launched an online continuing education program that serves as a preparatory course for BPS certification in sterile compounding.
One reason to recommend vitamin C is for skin health and chronic wound healing.
According to Purdue Pharma, Nalmefene HCl has a longer duration of action than naloxone, another opioid antagonist currently approved for emergency treatment of known or suspected opioid overdose.
Key opinion leaders address faulty reasoning behind vaccination aversion, for measles or otherwise, given trends in the disease-prevention paradigm.
In clinical trials, AbbVie's risankizumab-rzaa produced high rates of durable skin clearance – most people (82 and 81%) treated with the drug achieved 90% skin clearance (PASI 90) at 1 year, with the majority (56 and 60%) achieving complete skin clearance (PASI 100).
Jaron Stout, PharmD, owner, consulting pharmacist, Collaborative Pharmacy Consultants, discusses how pharmacists can work alongside physicians and other members of a primary care team, and help to relieve 'prescribing cascades.'
With measles cases on the rise globally and with an outbreak of measles in communities right here in the United States, adults should ensure they are adequately vaccinated against this serious and potentially fatal disease.
Some patients reportedly opt not to seek medical care, because of a lack of empathy and understanding care providers about their needs.
Report shows that salaries were either flat or declining for most of the surveyed physicians.
The Center for Medicare and Medicaid Innovation (CMMI) will be inviting primary care practices to participate in 5 new alternative payment models that will allow primary care practices to provide new types of services to their patients that are not supported by current Medicare payments.
Pembrolizumab (Keytruda, Merck) has received FDA approval as a first-line treatment in combination with axitinib (Inlyta) for patients with advanced renal cell carcinoma (RCC), making it the first indication for pembrolizumab in this patient population.
Precancerous cervical lesions, known as high-grade cervical lesions (CIN2+) can develop a few years after infection and have been used to monitor human papillomavirus (HPV) vaccine impact since cancers can take decades to develop.
What is causing KS's blood pressure to increase, despite maintaining a similar routine?
This approval marks the first generic naloxone nasal spray for use in a community setting by an individual without medical training.
Spring cleaning brings the opportunity to clean out unused and unwanted medicines that collect over time, just like old clothes from the closet or old food from the fridge.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Many health care professionals are being targeted by criminals, according to the DEA.
Failure to understand and appreciate the dynamics of the marketplace is costing pharmacy owners money.
Those who qualify and complete our survey are eligible to enter our drawing in which 1 lucky winner will receive a $250 American Express gift card.
The commercial availability of Bijuva offers an FDA approved alternative to marketed synthetic hormones or individual estrogen and progesterone products that have not been FDA-approved for combination use.
Antioxidants can be used to improve certain health conditions.
Alisha Barr, PharmD, asked her fellow pharmacist moms to donate supplies to her brother, who is deployed in Syria, and was overwhelmed by the response.
The study presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Amsterdam, Netherlands was a phase 2 randomized, active-controlled, double-blinded trial (N=444). All participants were ages 60 to 64 years.
Approved by the FDA on April 9, 2019, Amgen’s romosozumab-aqqg therapy (Evenity) is indicated for osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.
The vaccine will use a cell-based candidate vaccine virus (CVV) for 4 influenza strains identified by the World Health Organization (WHO) for the upcoming flu season.
Estimates suggest that by 2020, 1.5 to 1.75 million people in the U.S. will be living with wet AMD, a leading cause of blindness worldwide and a rapidly growing public health concern, according to Novartis.
Officials with the US Food and Drug Administration have approved a therapy designed to provide weight management aid to overweight adults.
Changing patient habits, especially dietary habits, is a routine struggle for many people diagnosed with type 2 diabetes.
